Neuberger Berman Group LLC Charles River Laboratories International, Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 266,823 shares of CRL stock, worth $55.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

266,823

Holding current value

$55.1 Million

% of portfolio

0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$203.52 - $273.43 $54.3 Million - $73 Million	266,823 New	266,823 $72.3 Million
Q4 2023 Feb 09, 2024	SELL	$164.52 - $238.84 $613,001 - $889,917	-3,726 Reduced 1.43%	257,634 $60.9 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $252,577 - $282,675	-1,299 Reduced 0.49%	261,360 $51.2 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $392,771 - $449,514	2,138 Added 0.82%	262,659 $55.2 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $712,487 - $965,082	3,713 Added 1.45%	260,521 $52.6 Million

Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $139,159 - $176,549	-706 Reduced 0.27%	256,808 $55.9 Million
Q3 2022 Nov 15, 2022	BUY	$182.44 - $250.54 $1.38 Million - $1.9 Million	7,565 Added 3.03%	257,514 $50.6 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $828,155 - $1.23 Million	4,057 Added 1.65%	249,949 $53.5 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $5.33 Million - $7.56 Million	-20,877 Reduced 7.83%	245,892 $68.8 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $425,872 - $543,800	1,212 Added 0.46%	266,769 $98.8 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $38.6 Million - $47.5 Million	-103,669 Reduced 28.08%	265,557 $108 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $13.7 Million - $17.3 Million	-46,454 Reduced 11.18%	369,226 $135 Million
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $30.7 Million - $36.8 Million	-122,800 Reduced 22.8%	415,680 $120 Million
Q4 2020 Feb 10, 2021	SELL	$222.0 - $252.62 $2.07 Million - $2.36 Million	-9,342 Reduced 1.71%	538,480 $134 Million
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $25.1 Million - $32.3 Million	-142,824 Reduced 20.68%	547,822 $124 Million
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $2.93 Million - $4.68 Million	-24,673 Reduced 3.45%	690,646 $120 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $6.62 Million - $11.9 Million	66,938 Added 10.32%	715,319 $90.3 Million
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $7.55 Million - $9.14 Million	59,863 Added 10.17%	648,381 $99 Million
Q3 2019 Nov 13, 2019	BUY	$125.07 - $143.67 $3.29 Million - $3.78 Million	26,295 Added 4.68%	588,518 $77.9 Million
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $1.14 Million - $1.37 Million	-9,203 Reduced 1.61%	562,223 $79.8 Million
Q1 2019 May 13, 2019	SELL	$104.82 - $146.73 $1.79 Million - $2.5 Million	-17,066 Reduced 2.9%	571,426 $83 Million
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $959,786 - $1.25 Million	-9,133 Reduced 1.53%	588,492 $66.6 Million
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $6.77 Million - $8.12 Million	-60,372 Reduced 9.18%	597,625 $80.4 Million
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $2.48 Million - $2.84 Million	-24,232 Reduced 3.55%	657,997 $73.9 Million
Q1 2018 May 08, 2018	SELL	$98.19 - $115.2 $3.69 Million - $4.33 Million	-37,590 Reduced 5.22%	682,229 $72.8 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $6.57 Million - $7.72 Million	-65,405 Reduced 8.33%	719,819 $78.8 Million
Q3 2017 Nov 15, 2017	BUY	$96.72 - $109.26 $75.9 Million - $85.8 Million	785,224	785,224 $84.8 Million

Others Institutions Holding CRL

# of Institutions

727

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Charles River Laboratories International, Inc. Transaction History